Compliance Rate
Compliance Rate
50.0%
Compliant submissions
2
Incompliant submissions
2
Total trials
4
My Organizations' Clinical Trials
Showing 225 of 1308 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 06/18/21
End: 06/18/21
Due: 06/18/22
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 12/01/28
Due: 12/01/29
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 04/01/19
Due: 04/01/20
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 08/13/24
Due: 08/13/25
Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 04/26/18
Due: 04/26/19
Phase: N/A
Priority: Normal
Start: 01/02/19
End: 10/09/20
Due: 10/09/21
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 05/02/18
Due: 05/02/19
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 07/15/24
End: 05/15/25
Due: 05/15/26
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 09/26/26
Due: 09/26/27
Phase: N/A
Priority: Normal
Start: 08/29/16
End: 10/02/17
Due: 10/02/18
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 10/30/21
Due: 10/30/22
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 06/18/20
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 01/07/25
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 04/15/25
End: 05/30/25
Due: 05/30/26
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 01/05/16
End: 08/12/20
Due: 08/12/21